Suzanne C Morris Selected Research

Mastocytosis

3/2005	Molecular mechanisms of anaphylaxis: lessons from studies with murine models.
4/2002	Pathways of anaphylaxis in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne C Morris Research Topics

Disease

9	Anaphylaxis (Anaphylactic Shock) 01/2022 - 04/2002
6	Hypersensitivity (Allergy) 01/2022 - 04/2003
3	Asthma (Bronchial Asthma) 01/2017 - 03/2004
3	Infections 10/2016 - 07/2003
2	Hypothermia 01/2022 - 06/2013
2	Shock 12/2013 - 06/2013
2	Inflammation (Inflammations) 10/2010 - 04/2003
2	Mastocytosis 03/2005 - 04/2002
1	Food Hypersensitivity (Food Allergy) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Immediate Hypersensitivity 06/2013
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2010
1	Weight Loss (Weight Reduction) 10/2010
1	Virus Diseases (Viral Diseases) 08/2010
1	Hyperplasia 04/2005
1	Respiratory Hypersensitivity 04/2005

Drug/Important Bio-Agent (IBA)

8	Interleukin-4 (Interleukin 4)IBA 01/2021 - 04/2003
7	Immunoglobulin E (IgE)IBA 01/2022 - 04/2002
6	CytokinesIBA 01/2021 - 04/2003
6	AntigensIBA 01/2021 - 04/2002
5	Immunoglobulin G (IgG)IBA 01/2018 - 04/2002
4	Interleukin-13IBA 10/2010 - 04/2003
3	AllergensIBA 01/2022 - 03/2006
3	Histamine (Histamine Dihydrochloride)FDA Link 06/2013 - 04/2002
2	Pharmaceutical PreparationsIBA 01/2022 - 07/2003
2	IgE Receptors (Fc epsilon RI)IBA 01/2020 - 04/2003
2	AntibodiesIBA 01/2018 - 03/2005
2	Monoclonal AntibodiesIBA 12/2013 - 06/2013
2	anti-IgE antibodiesIBA 06/2013 - 04/2002
2	Platelet Activating FactorIBA 03/2005 - 04/2002
1	Histamine Receptors (Histamine Receptor)IBA 01/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Syk KinaseIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Immunoglobulin Variable RegionIBA 01/2021
1	ligelizumabIBA 01/2020
1	Omalizumab (Xolair)FDA Link 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 06/2013
1	CalciumIBA 06/2013
1	Hemoglobins (Hemoglobin)IBA 10/2010
1	InterferonsIBA 10/2010
1	Interleukin-7 (Interleukin 7)IBA 08/2010
1	LectinsIBA 08/2010
1	Interleukin-15 (Interleukin 15)IBA 08/2010
1	EpitopesIBA 03/2006
1	Blocking AntibodiesIBA 03/2006
1	IgG Receptors (Fc gamma RI)IBA 03/2006
1	Fc gamma receptor IIBIBA 03/2006
1	Immunoglobulin A (IgA)IBA 03/2005
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2005
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 03/2004
1	Immunoglobulin D (IgD)IBA 04/2002
1	Immunoglobulin IsotypesIBA 04/2002

Therapy/Procedure

1	Therapeutics 01/2022
1	Intravenous Injections 01/2020
1	Ligation 12/2013